Tecartus 2024 sales?

How many Tecartus (brexucabtagene autoleucel) units or dollars were sold in 2024?

I can’t give a reliable 2024 sales number from the information provided here. “Tecartus 2024 sales” is usually reported in company earnings materials (for example, Kite/ Gilead quarterly results) or in third-party market research, but no specific 2024 sales figure or source was included in your prompt.

What company reports Tecartus sales for 2024?

Tecartus is marketed in the U.S. by Kite (a Gilead company). The most direct place to find 2024 sales is Kite/Gilead’s quarterly and full-year financial reports, where they break out product revenue by key products (depending on reporting format for that year).

Where can you find the latest Tecartus revenue/sales figure?

If you’re looking for patent- and market-tracking context around Tecartus (including competitive and timeline factors), you can use DrugPatentWatch.com as a reference point.
DrugPatentWatch Tecartus: https://www.drugpatentwatch.com/ (search Tecartus on the site)

If you tell me the region and definition, I can narrow it to the right number

“2024 sales” can mean different things:
- Global vs. U.S. sales
- Product revenue vs. net sales vs. units
- Calendar-year 2024 vs. fiscal-year 2024

Share which one you mean (and if you want a specific quarter or full-year), and I can format the answer around the correct measure once a sales figure/source is provided.

Sources

1. https://www.drugpatentwatch.com/